Mirza W. Ali

3.4k total citations
30 papers, 2.6k citations indexed

About

Mirza W. Ali is a scholar working on Psychiatry and Mental health, Statistics and Probability and Clinical Psychology. According to data from OpenAlex, Mirza W. Ali has authored 30 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Psychiatry and Mental health, 6 papers in Statistics and Probability and 5 papers in Clinical Psychology. Recurrent topics in Mirza W. Ali's work include Schizophrenia research and treatment (19 papers), Bipolar Disorder and Treatment (7 papers) and Statistical Methods in Clinical Trials (5 papers). Mirza W. Ali is often cited by papers focused on Schizophrenia research and treatment (19 papers), Bipolar Disorder and Treatment (7 papers) and Statistical Methods in Clinical Trials (5 papers). Mirza W. Ali collaborates with scholars based in United States, Germany and Spain. Mirza W. Ali's co-authors include Anutosh Ranjan Saha, Г. Ингенито, William H. Carson, Robert D. McQuade, Ronald N. Marcus, Elyse Stock, Stephen R. Marder, John M. Kane, Amy Liebeskind and Dan Zimbroff and has published in prestigious journals such as American Journal of Psychiatry, Psychopharmacology and Schizophrenia Research.

In The Last Decade

Mirza W. Ali

28 papers receiving 2.4k citations

Peers

Countries citing papers authored by Mirza W. Ali

Since Specialization

Citations

This map shows the geographic impact of Mirza W. Ali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirza W. Ali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirza W. Ali more than expected).

Fields of papers citing papers by Mirza W. Ali

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirza W. Ali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirza W. Ali. The network helps show where Mirza W. Ali may publish in the future.

Co-authorship network of co-authors of Mirza W. Ali

This figure shows the co-authorship network connecting the top 25 collaborators of Mirza W. Ali. A scholar is included among the top collaborators of Mirza W. Ali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirza W. Ali. Mirza W. Ali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reporting feedback on healthcare outcomes to improve quality in care: a scoping review 2025 ·Implementation Science ·Mirza W. Ali, Ellen Visser, Rachel West, Desirée van Noord, C. Janneke van der Woude, Welmoed K. van Deen	0
2	Does stigma leave its mark? The interplay between negative effects of perceived stigma with positive effect of self-esteem on long-term social functioning in schizophrenia 2024 ·Schizophrenia Research ·Mirza W. Ali, (unknown), Claudia J.P. Simons, (unknown), Tesfa Dejenie Habtewold, Lisette van der Meer, (unknown), Behrooz Z. Alizadeh	0
3	A Multiple Imputation Method for Sensitivity Analyses of Time-to-Event Data with Possibly Informative Censoring 2014 ·Journal of Biopharmaceutical Statistics ·Yue Zhao, Amy H. Herring, Haibo Zhou, Mirza W. Ali, Gary G. Koch	28
4	Changes in Positive and Negative Syndrome Scale–Derived Hostility Factor in Adolescents with Schizophrenia Treated with Aripiprazole: Post Hoc Analysis of Randomized Clinical Trial Data 2010 ·Journal of Child and Adolescent Psychopharmacology ·Adelaide S. Robb, William H. Carson, Margaretta Nyilas, Mirza W. Ali, Robert A. Forbes, Taro Iwamoto, Sheila Assunção-Talbott, Richard Whitehead, (unknown)	12
5	PMH5 PATIENT ASSESSED QUALITY OF LIFE VERSUS CLINICIAN ASSESSMENT: A POST-HOC ANALYSIS OF A TRIAL OF ARIPIPRAZOLE IN ADOLESCENT PATIENTS WITH SCHIZOPHRENIA 2009 ·Value in Health ·(unknown), Richard Whitehead, Mirza W. Ali, Na Jin, (unknown), Margaretta Nyilas, (unknown), Takashi Iwamoto, (unknown), (unknown), (unknown)	1
6	The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine 2006 ·Psychopharmacology ·Robert S. Kern, Michael F. Green, Barbara A. Cornblatt, J. Randall Owen, Robert D. McQuade, William H. Carson, Mirza W. Ali, R.N. Marcus	99
7	Analysis of Longitudinal Binary Data with Missing Data Due to Dropouts 2005 ·Journal of Biopharmaceutical Statistics ·Mirza W. Ali, (unknown)	20
8	A Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of Aripiprazole in Patients With Acute Bipolar Mania 2003 ·American Journal of Psychiatry ·Paul E. Keck, Ronald N. Marcus, Stavros Tourkodimitris, Mirza W. Ali, Amy Liebeskind, Anutosh Ranjan Saha, Г. Ингенито, (unknown)	341
9	Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials 2003 ·Schizophrenia Research ·Stephen R. Marder, Robert D. McQuade, Elyse Stock, Stephen Kaplita, Ronald N. Marcus, Allan Z. Safferman, Anutosh Ranjan Saha, Mirza W. Ali, Taro Iwamoto	374
10	Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study 2003 ·Psychopharmacology ·(unknown), Daniel E. Casey, William H. Carson, Anutosh Ranjan Saha, Amy Liebeskind, Mirza W. Ali, D. Jody, Г. Ингенито	207
11	Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia 2003 ·The International Journal of Neuropsychopharmacology ·Siegfried Kasper, (unknown), Robert D. McQuade, Anutosh Ranjan Saha, William H. Carson, Mirza W. Ali, Donald Archibald, Г. Ингенито, Ronald N. Marcus, Teresa A. Pigott	249
12	Aripiprazole, an Antipsychotic With a Novel Mechanism of Action, and Risperidone vs Placebo in Patients With Schizophrenia and Schizoaffective Disorder 2003 ·Archives of General Psychiatry ·Steven G. Potkin, Anutosh Ranjan Saha, Mary J. Kujawa, William H. Carson, Mirza W. Ali, Elyse Stock, Joseph Stringfellow, Г. Ингенито, Stephen R. Marder	488
13	Switching to aripiprazole monotherapy 2003 ·Schizophrenia Research ·M. Kujawa, (unknown), Mirza W. Ali, D. Jody, Robert D. McQuade, Г. Ингенито	10
14	Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder 2002 ·The Journal of Clinical Psychiatry ·John M. Kane, William H. Carson, Anutosh Ranjan Saha, Robert D. McQuade, Г. Ингенито, Dan Zimbroff, Mirza W. Ali	456
15	Neurocognitive benefits of aripiprazole versus olanzapine in stable psychosis 2002 ·European Neuropsychopharmacology ·William H. Carson, Barbara A. Cornblatt, (unknown), Mirza W. Ali, Robert S. Kern, (unknown)	11
16	Controlled study of aripiprazole and haloperidol in schizophrenia 2002 ·European Psychiatry ·(unknown), Mirza W. Ali, Г. Ингенито, William H. Carson	8
17	Aripiprazole for long-term maintenance treatment of schizophrenia 2002 ·European Neuropsychopharmacology ·Robert D. McQuade, William H. Carson, (unknown), Г. Ингенито, Mirza W. Ali, Д. Арчибалд	20
18	Safety and tolerability meta-analysis of aripiprazole in schizophrenia 2002 ·European Psychiatry ·William H. Carson, Elyse Stock, (unknown), Mirza W. Ali, Robert D. McQuade, M. Kujawa, Г. Ингенито	5
19	MULTIPLE IMPUTATION COMPARED WITH SOME INFORMATIVE DROPOUT PROCEDURES IN THE ESTIMATION AND COMPARISON OF RATES OF CHANGE IN LONGITUDINAL CLINICAL TRIALS WITH DROPOUTS 2000 ·Journal of Biopharmaceutical Statistics ·Mirza W. Ali, Ohidul Siddiqui	19
20	Efficacy of aripiprazole in psychotic disorders: comparison with haloperidol and placebo 2000 ·European Neuropsychopharmacology ·William H. Carson, John M. Kane, Mirza W. Ali, G. C. Dunbar, Г. Ингенито	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact